Article Versions Notes

Muranaka Y, Mizutani A, Kobayashi M, Nakamoto K, Matsue M, Takagi F, Okazaki K, Nishi K, Yamazaki K, Nishii R, et al. ¹²³I-BMIPP, a Radiopharmaceutical for Myocardial Fatty Acid Metabolism Scintigraphy, Could Be Utilized in Bacterial Infection Imaging. Pharmaceutics. 2022; 14(5):1008. https://doi.org/10.3390/pharmaceutics14051008

Muranaka, Yuka, Asuka Mizutani, Masato Kobayashi, Koya Nakamoto, Miki Matsue, Fumika Takagi, Kenichi Okazaki, Kodai Nishi, Kana Yamazaki, Ryuichi Nishii, and et al. 2022. "¹²³I-BMIPP, a Radiopharmaceutical for Myocardial Fatty Acid Metabolism Scintigraphy, Could Be Utilized in Bacterial Infection Imaging" Pharmaceutics 14, no. 5: 1008. https://doi.org/10.3390/pharmaceutics14051008

Muranaka, Y., Mizutani, A., Kobayashi, M., Nakamoto, K., Matsue, M., Takagi, F., Okazaki, K., Nishi, K., Yamazaki, K., Nishii, R., Shikano, N., Okamoto, S., Maki, H., & Kawai, K. (2022). ¹²³I-BMIPP, a Radiopharmaceutical for Myocardial Fatty Acid Metabolism Scintigraphy, Could Be Utilized in Bacterial Infection Imaging. Pharmaceutics, 14(5), 1008. https://doi.org/10.3390/pharmaceutics14051008